The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer.

Gaffney, Christopher

The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer. [electronic resource] - The Journal of urology 07 2019 - 96-101 p. digital

Publication Type: Evaluation Study; Journal Article

1527-3792

10.1097/JU.0000000000000170 doi


Aged
Biomarkers, Tumor--genetics
Biopsy, Large-Core Needle
Clinical Decision-Making--methods
Gene Expression Profiling--methods
Humans
Male
Middle Aged
Neoplasm Grading
Patient Selection
Prostate--pathology
Prostatic Neoplasms--diagnosis
Retrospective Studies
Risk Assessment--methods
Risk Factors